FDA could erase OTC exemption from device identifier rule

02/11/2013 | Clinica (subscription required)

Over-the-counter medical technologies might not be excluded from the unique device identifier rule being prepared for publication in June by the FDA. "There's a lot of interest in not seeing this exemption in the final rule so we're taking this into account," said Jay Crowley, senior adviser on patient safety for the FDA.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN